Natural killer cells and tumor metastasis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Archives of pharmacal research

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12272-017-0951-9PMID 28871566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer

  2017cited by this paper
• High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer

  2017influential reference
• IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours

  2017cited by this paper
• Interleukin 32, inflammation and cancer

  2017cited by this paper
• Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility

  2016cited by this paper
• Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration

  2016cited by this paper
• PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

  2016cited by this paper
• Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15

  2016cited by this paper
• Mammary-tumor-educated B cells acquire LAP/TGF-β and PD-L1 expression and suppress anti-tumor immune responses.

  2016cited by this paper
• Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells

  2016cited by this paper
• Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial–mesenchymal transition, invasion, and metastasis in pancreatic cancer cells

  2016cited by this paper
• Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models

  2016cited by this paper
• NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma

  2016cited by this paper
• Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression

  2015cited by this paper
• Podocalyxin-like protein 1 functions as an immunomodulatory molecule in breast cancer cells.

  2015cited by this paper
• Inflammatory mediators, tumor necrosis factor-α and interferon-γ, induce EMT in human PTC cell lines.

  2015cited by this paper
• Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients

  2015cited by this paper
• Human fused NKG2D–IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells

  2015cited by this paper
• Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression.

  2015cited by this paper
• Advantages and applications of CAR-expressing natural killer cells

  2015cited by this paper
• Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

  2015cited by this paper
• TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells.

  2015cited by this paper
• Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction

  2014cited by this paper
• Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression

  2014cited by this paper
• Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells.

  2014cited by this paper
• Expression of activating receptors on natural killer cells from AIDS-related lymphoma patients

  2014cited by this paper
• CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

  2014cited by this paper
• IL-32 promotes breast cancer cell growth and invasiveness

  2014cited by this paper
• Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches

  2014cited by this paper
• Interleukin-32 Increases Human Gastric Cancer Cell Invasion Associated with Tumor Progression and Metastasis

  2014cited by this paper
• NK Cell Phenotypic Modulation in Lung Cancer Environment

  2014cited by this paper
• Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.

  2013cited by this paper
• Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.

  2013cited by this paper
• M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway

  2013cited by this paper
• A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells.

  2013cited by this paper
• Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer

  2013influential reference
• Hypoxia downregulates the expression of activating receptors involved in NK‐cell‐mediated target cell killing without affecting ADCC

  2013cited by this paper
• Membrane-Type 6 Matrix Metalloproteinase Regulates the Activation-Induced Downmodulation of CD16 in Human Primary NK Cells

  2013cited by this paper
• Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity.

  2013cited by this paper
• Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells

  2013cited by this paper
• Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression.

  2013cited by this paper
• Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation

  2013cited by this paper
• Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity

  2013cited by this paper
• Invasion-associated genes identified by gene expression profiling in extranodal natural killer/T-cell lymphoma, nasal type

  2013cited by this paper
• Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody‐based anti‐tumour immunotherapy

  2013cited by this paper
• Epithelial–Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor

  2013cited by this paper
• Natural killer cells: a review of manufacturing and clinical utility

  2013cited by this paper
• Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

  2012cited by this paper
• HLA‐E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression

  2012cited by this paper
• Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis

  2012cited by this paper
• Molecular link mechanisms between inflammation and cancer.

  2012cited by this paper
• Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.

  2012cited by this paper
• Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2.

  2012cited by this paper
• NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study

  2012cited by this paper
• Combination strategies to enhance antitumor ADCC.

  2012cited by this paper
• Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO.

  2012cited by this paper
• Accessories to the crime: functions of cells recruited to the tumor microenvironment.

  2012cited by this paper
• Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

  2011influential reference
• IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.

  2011cited by this paper
• Overexpression of IL-32α Increases Natural Killer Cell-mediated Killing through Up-regulation of Fas and UL16-binding protein 2 (ULBP2) Expression in Human Chronic Myeloid Leukemia Cells*

  2011cited by this paper
• Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma.

  2011cited by this paper
• Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma

  2011cited by this paper
• Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines

  2011cited by this paper
• MMP9 mediates MICA shedding in human osteosarcomas

  2011cited by this paper
• Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.

  2011cited by this paper
• Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands

  2011cited by this paper
• The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

  2010cited by this paper
• Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases

  2010cited by this paper
• Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer.

  2010cited by this paper
• Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

  2010cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor

  2009cited by this paper
• Tumour necrosis factor and cancer

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection

  2009cited by this paper
• Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

  2009cited by this paper
• Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expression

  2009cited by this paper
• NK cells and cancer immunosurveillance

  2008cited by this paper
• The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.

  2008cited by this paper
• A high concentration of MMP-2/gelatinase A and MMP-9/gelatinase B reduce NK cell-mediated cytotoxicity against an oral squamous cell carcinoma cell line.

  2008cited by this paper
• Fc-dependent expression of CD137 on human NK cells: insights into "agonistic" effects of anti-CD137 monoclonal antibodies.

  2008cited by this paper
• Functions of natural killer cells

  2008cited by this paper
• Inflammation and cancer: An ancient link with novel potentials

  2007cited by this paper
• Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

  2007cited by this paper
• Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment

  2007cited by this paper
• SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion

  2007cited by this paper
• CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1

  2007cited by this paper
• Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells.

  2006cited by this paper
• The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function.

  2006cited by this paper
• The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

  2006cited by this paper
• Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.

  2005cited by this paper
• Coordination of activating and inhibitory signals in natural killer cells.

  2005cited by this paper
• Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

  2005cited by this paper
• IL-12 or IL-4 Prime Human NK Cells to Mediate Functionally Divergent Interactions with Dendritic Cells or Tumors1

  2005cited by this paper
• Molecular Dissection of 2B4 Signaling: Implications for Signal Transduction by SLAM-Related Receptors

  2004cited by this paper
• Polymorphisms in FcγRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenstrom's macroglobulinemia.

  2004cited by this paper
• The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic1

  2004influential reference

• Suppressor effects of carrots on azoxymethane/dextran sulfate sodium-induced colon cancer according to cultivation method

  2025cites this paper
• Awake versus intubated video-assisted thoracoscopic surgery for pleural disease: a retrospective cohort study from a single tertiary center

  2025cites this paper
• Development and validation of a basement membrane inflammatory response gene signature in lung adenocarcinoma

  2025cites this paper
• Blocking CXCR3B Expression Increases Tumor Aggressiveness in Hepatocellular Carcinoma

  2024cites this paper
• Role of Interleukin(IL)-6 in NK Activity to Hypoxic-Induced Highly Invasive Hepatocellular Carcinoma(HCC) Cells

  2023cites this paper
• Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer.

  2023cites this paper
• DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma

  2023cites this paper
• Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review

  2022cites this paper
• Chronic inflammation, cancer development and immunotherapy

  2022cites this paper
• The antitumor effect of natural killer cells against hepatocellular carcinoma through CXCL9

  2022cites this paper
• PNSA, a Novel C-Terminal Inhibitor of HSP90, Reverses Epithelial–Mesenchymal Transition and Suppresses Metastasis of Breast Cancer Cells In Vitro

  2021cites this paper
• Cancer drug resistance induced by EMT: novel therapeutic strategies

  2021cites this paper
• Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

  2021cites this paper
• CMAR_A_257492 6727..6737

  2020influential citation
• Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients

  2020cites this paper
• Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells

  2020cites this paper
• Omega‐3 Polyunsaturated Fatty Acids and Lung Cancer: nutrition or Pharmacology?

  2020cites this paper
• Attenuated anti-tumor activity of NK-92 cells by invasive human breast carcinoma MDA-MB-231 cells

  2020cites this paper
• Prognostic significance of peripheral blood‐derived neutrophil/lymphocyte ratio in patients with digestive cancer

  2019cites this paper
• More efficient use of HER targeting agents in cancer therapy

  2019cites this paper
• Immunostimulatory effect of kumquat (Fortunella crassifolia) and its constituents, β-cryptoxanthin and R-limonene.

  2019cites this paper
• Immunophenotypic characterization of sphere-forming cells derived from the human renal cell carcinoma cell line 786-O.

  2018cites this paper
• Cytokine-Modulated Natural Killer Cells Differentially Regulate the Activity of the Hepatitis C Virus

  2018cites this paper
• Immune effects after uniportal nonintubated video-thoracoscopic operations

  2018cites this paper
• Angiogenin and the MMP9‐TIMP2 axis are up‐regulated in proangiogenic, decidual NK‐like cells from patients with colorectal cancer

  2018cites this paper
• Lactic Acid Bacteria from Kefir Increase Cytotoxicity of Natural Killer Cells to Tumor Cells

  2018cites this paper
• jmbReview Improved Anti-Cancer Effect of Curcumin on Breast Cancer Cells by Increasing the Activity of Natural Killer Cells

  year unknowncites this paper